This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Vifor sees EU decision in iron-medicine antitrust probe published

( November 15, 2024, 08:54 GMT | Official Statement) -- MLex Summary: Vifor today saw the European Commission issue the summary version of its earlier decision to accept the company's proposal to end an antitrust probe. In July, the watchdog closed an investigation that looked into potentially misleading statements about a rival's product by making the company's offer legally binding. Vifor was obliged to begin an information campaign to rectify and undo the effects of earlier messages about the safety of the iron-deficiency product Monofer, produced by Pharmacosmos. The competition enforcer also released the hearing officer's final report today. The report of the hearing officer and the summary decision are attached. Case reference is AT.40577. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login